
Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
October 2

Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
• Providing clinical leadership and strategic medical input for all clinical deliverables in the assigned project or section of a clinical program. • Leading development of clinical sections of trial and program level regulatory documents. • Driving execution of the program and/or clinical trial in partnership. • Supporting the Clinical Development program lead by providing medical input into Clinical Development Plan (CDP) and Clinical Trial Protocol (CTP) reviews and contributing to/driving development of disease clinical standards for new disease areas. • Literature review, KOL interactions, attending scientific meetings, and presenting the clinical development plan to the relevant internal stakeholders to help shape the new indication selection process. • Leading the protocol development for the new selected indication/s, working closely with the relevant external and internal stakeholders • As a medical specialist, supporting and leading interactions with external and internal partners and decision boards. • Medical monitoring of the assigned clinical trial/s, data and safety review and working closely with the clinical operations, and external partners to oversee conduct of the assigned clinical trial/s. • Working closely with the internal and external stakeholders as well as the clinical sites, and investigators to help ensure timely recruitment.
• MD, PhD, or PharmD required • Experience in clinical development is required. Experience in rare diseases, neurology is highly preferred. • Proven ability to work with cross functional teams, study vendors and clinical trial sites. • Strong business communication skills, written and verbal, and comfortable with giving presentations internally and externally. • Knowledge – thorough understanding of GCP/regulatory requirements. • Proactiveness – the ability to identify challenges and risks and implement appropriate actions with some supervision. • Motivation – highly motivated and self-starter; able to organize and perform complex tasks with minimal supervision. • Collaboration – to coordinate activities of internal cross-functional study team as well as external vendors as applicable. • Open-mindedness – listen to ideas from others and seek guidance when applicable; inform manager as situations arise to brainstorm and seek best solutions.
• Health insurance • Professional development opportunities • Flexible work arrangements
Apply NowOctober 2
Director overseeing R&D Learning initiatives within the company. Focused on business partner collaboration and strategic leadership.
🇺🇸 United States – Remote
💰 $28.5G Post-IPO Debt on 2022-12
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
October 2
Lead Northeast market development and wholesale sales for Specialized bicycles. Manage sales strategy, team coaching, forecasts, budgets, and account relationships with regular territory travel.
October 2
Workforce Planning and Optimization Director at Equip ensuring effective staffing strategies for treatment services. Collaborate cross-functionally to ensure patient care and operational excellence.
October 2
Health Systems Director at CG Oncology, focusing on strategic account management in the biopharmaceutical industry. Engaging with key decision makers to enhance patient access and drive demand.
🇺🇸 United States – Remote
💵 $183k - $215k / year
💰 $120M Series E on 2022-11
⏰ Full Time
🔴 Lead
👔 Director
October 2
Director of Portfolio Management at Bio-Techne driving cross-functional product strategy and optimization. Leading lifecycle management and execution for diverse product categories.